Mark L. Baum - Aug 14, 2023 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)

Role: Chief Executive Officer, Director
Signature: /s/ Mark L. Baum
Stock symbol: HROW
Transactions as of: Aug 14, 2023
Transactions value $: $98,890
Form type: 4
Date filed: 8/15/2023, 07:30 AM
Previous filing: Jul 20, 2023
Next filing: Nov 16, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HROW	Common Stock	Purchase	$98.9K	+5.8K	+0.29%	$17.05	2.02M	Aug 14, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.01 to $17.06, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.01 to $17.06, inclusive. The reporting person undertakes to provide to Harrow Health, Inc. ("Harrow"), any security holder of Harrow, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.